The Event is Live Today

Access the Event

Keynote Speaker

  • Luigi Naldini

    Luigi Naldini

    San Raffaele Telethon Institute for Gene Therapy and San Raffaele University, Milan, Italy

    Luigi Naldini, M.D., Ph.D., is Professor of Cell and Tissue Biology and of Gene and Cell Therapy at the San Raffaele University School of Medicine and Scientific Director of the San Raffaele Telethon Institute for Gene Therapy (Milan, Italy). He received his medical degree from the University of Turin (Italy) and his PhD from the University “La Sapienza” of Rome (Italy).

    For the past 25 years he has pioneered the development and application of lentiviral vectors for gene therapy, which have become one of the most widely used tools in biomedical research and, upon recently entering clinical testing, are providing a long-sought hope of cures for several currently untreatable and otherwise deadly human diseases. Throughout this time, he has continued to investigate new strategies to overcome the major hurdles to safe and effective gene transfer, bringing about innovative solutions that are not only being translated into new therapeutic strategies for genetic disease and cancer, but have also yielded novel insights into haematopoietic stem cell function, induction of immunological tolerance, and tumour angiogenesis.

    Professor Naldini's work has also contributed to advancing the use of artificial nucleases for targeted genome editing in cell- and gene therapy. To date, he has published over 290 scientific papers, and his SCOPUS Author h-index is 105. He is also co-founder of three innovative biotech start-up companies: Genenta (recently listed on Nasdaq), Epsilen Bio (now acquired by Chroma Medicine) and Genespire.

    Google Scholar ORCIID Lab Webpage

Confirmed Scientific Speakers

  • Alessia Cavazza

    Alessia Cavazza

    University College London, United Kingdom

    Alessia is a Group Leader and Associate Professor in Gene Therapy at University College London's Great Ormond Street Institute of Child Health.

    Google Scholar ORCIID LinkedIn Lab Webpage

  • Alvin Luk

    Alvin Luk

    HuidaGene Therapeutics, Inc.

    Alvin Luk is Co-Founder, CEO, and Head of Medical at HuidaGene Therapeutics, Inc.

    Alvin will speak at the CRISPRMED24 Virtual Event 22nd April.

    Google Scholar LinkedIn Company Webpage

  • André Cohnen

    André Cohnen

    Bayer Pharmaceuticals

    André is the VP and Head of Genomic Medicine at Bayer Pharmaceuticals.

    ORCIID LinkedIn Company Webpage

  • Andrew Bellinger

    Andrew Bellinger

    Verve Therapeutics

    Andrew is the Chief Scientific Officer and Founder of Verve Therapeutics, a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. He's also a Co-Founder at Corner Therapeutics.

    LinkedIn Company Webpage

  • Angelo Lombardo

    Angelo Lombardo

    San Raffaele - Telethon Institute for Gene Therapy, Italy

    Angelo is a Group Leader at the San Raffaele - Telethon Institute for Gene Therapy (SR-Tiget) and Professor at the Vita-Salute San Raffaele University in Milano, Italy. He is also a Co-founder of Chroma Medicine.

    Google Scholar ORCIID Lab Webpage Company Webpage

  • Anna Cereseto

    Anna Cereseto

    University of Trento, Italy

    Anna is a Professor and Vice Director of the Department of Cellular, Computational and Integrative Biology at University of Trento, where she leads the Laboratory of Molecular Virology. She is also co-founder of Alia Therapeutics.

    Google Scholar ORCIID LinkedIn Lab Webpage

  • Antonio Casini

    Antonio Casini

    Alia Therapeutics

    Antonio is a Co-Founder and CTO at Alia Therapeutics.

    LinkedIn Company Webpage

  • Avencia Sánchez-Mejías

    Avencia Sánchez-Mejías

    Integra Therapeutics

    Avencia is the CEO & co-founder at Integra Therapeutics.

    Google Scholar ORCIID LinkedIn Company Webpage

  • Ayal Hendel

    Ayal Hendel

    Bar-Ilan University, Israel.

    Ayal is a Principal Investigator at The Mina and Everard Goodman Faculty of Life Sciences at Bar-Ilan University.

    Google Scholar ORCIID LinkedIn Lab Webpage

  • Ben Kleinstiver

    Ben Kleinstiver

    Harvard Medical School and Massachusetts General Hospital

    Ben is an Assistant Professor at the Center for Genomic Medicine, at Harvard Medical School, as well as a MGH Research Scholar at Massachusetts General Hospital.

    Google Scholar ORCIID LinkedIn Lab Webpage

  • Bernhard Schmierer

    Bernhard Schmierer

    Karolinska Institutet, Sweden

    Bernhard is the head of the CRISPR Functional Genomics unit at the SciLifeLab and Karolinska Institutet in Stockholm, Sweden.

    Google Scholar ORCIID LinkedIn Lab Webpage

  • Brian Cosgrove

    Brian Cosgrove

    Tune Therapeutics

    Brian Cosgrove is a Principal Scientist at Tune Therapeutics and the research lead for the Hepatitis B program.

    Brian will speak at the CRISPRMED24 Virtual Event 22nd April.

    Google Scholar LinkedIn Company Webpage

  • Daniel Schraivogel

    Daniel Schraivogel

    EMBL

    Research Staff Scientist at EMBL.

    LinkedIn Lab Webpage

  • Fiona M. Behan

    Fiona M. Behan

    GlaxoSmithKline Pharma

    Fiona is the Scientific Director at GlaxoSmithKline Pharma.

    Google Scholar LinkedIn Company Webpage

  • Jan Gorodkin

    Jan Gorodkin

    University of Copenhagen, Denmark

    Jan is a Professor and Group Leader at the University of Copenhagen.

    Google Scholar ORCIID LinkedIn Lab Webpage

  • Jan Nelis

    Jan Nelis

    Ariya Bio

    Jan is a Co-Founder and Project Lead at Ariya Bio.

    LinkedIn Company Webpage

  • Jin Chen

    Jin Chen

    Altos Labs, USA

    Jin is a Principal Investigator at Altos Labs and an assistant professor at UT Southwestern Medical Center in Dallas, USA.

    Google Scholar ORCIID LinkedIn Lab Webpage

  • Jonas Hink

    Jonas Hink

    SNIPR Biome

    Jonas Hink is the Chief Medical Officer at SNIPR Biome.

    Company Webpage

  • Julien Valton

    Julien Valton

    Cellectis

    Julien is the Vice-President of Gene Therapy at Cellectis.

    LinkedIn Company Webpage

  • Karim Benabdellah

    Karim Benabdellah

    Fundación Pública Andaluza Progreso y Salud, Spain.

    Karim is a Senior Scientist at the GENyO. Pfizer-University of Granada-Junta de Andalucia Center for Genomics and Oncological Research in Granada, Spain.

    Google Scholar ORCIID LinkedIn Edición Genómica aplicada a Terapias Avanzas (eGATA) - Genyo

  • Karina Thorn

    Karina Thorn

    Novo Nordisk

    Karina is Corporate Vice President, PhD, Head of Research, Global Nucleic Acid Therapies (GNAT) at Novo Nordisk.

    LinkedIn Company Website

    Karina has a PhD in Biochemistry from the Faculty of Pharmaceutical Sciences, University of Copenhagen, Denmark. After working several years in Boston, US, Karina joined Novo Nordisk in 2014.

    Since then, she has successfully been driving research projects, portfolio innovation, and preclinical research areas via scientific, strategic, and people leadership. Furthermore, and as a result of her passion for unlocking therapeutic innovation via emerging technologies, Karina has been instrumental in establishing a broad palette of external Novo Nordisk partnerships and acquisitions.

    Karina is a strong and innovative leader who has committed her career to improving the lives of millions of people worldwide living with serious chronic conditions, by unleashing creativity through her collaborative ‘United by Science’ drive and ‘transforming intracellular therapies from the few to the many’ fuel.

  • Laura Sepp-Lorenzino

    Laura Sepp-Lorenzino

    Laura is the Executive Vice President and Chief Scientific Officer at Intellia Therapeutics.

    Google Scholar LinkedIn Company Webpage

  • Luigi Naldini

    Luigi Naldini

    San Raffaele Telethon Institute for Gene Therapy and San Raffaele University, Milan, Italy

    Luigi is the Director of the San Raffaele Telethon Institute for Gene Therapy (TIGET) and a Prof. of Histology and Gene and Cell Therapy at the Vita-Salute San Raffaele University in Milan.

    Google Scholar ORCIID Lab Webpage

  • Manuel Kaulich

    Manuel Kaulich

    Goethe University Frankfurt, Germany

    Manuel is a LOEWE-FCI Professor at Goethe University Frankfurt. He is also the Chief Scientific Officer at Vivlion, and the head of the Frankfurt CRISPR Screening Center.

    Google Scholar ORCIID LinkedIn Lab Webpage Company Webpage

  • Marcello Maresca

    Marcello Maresca

    AstraZeneca

    Marcello is the Senior Director of Genome Engineering at AstraZeneca.

    ORCIID LinkedIn Company Webpage

  • Marianne Carlon

    Marianne Carlon

    Catholic University (KU) Leuven, Belgium

    Marianne is an Ass. Prof. at the Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE) and the Center for Molecular Medicine of the KU Leuven Faculty of Medicine.

    Google Scholar ORCIID LinkedIn BREATHE Webpage KU Leuven Webpage

  • Michael Krohn

    Michael Krohn

    Akribion Genomics

    Michael Krohn is Co-CEO at Akribion Genomics.

    Michael will speak at the CRISPRMED24 Virtual Event 22nd April.

    LinkedIn Company Webpage

  • Nikhil Gupta

    Nikhil Gupta

    Cancer Research UK

    Nikhil is a Principal Scientist at the Joint AstraZeneca-Cancer Research Horizons Functional Genomics Centre, UK.

    Google Scholar LinkedIn Lab Webpage

  • Paula Rio

    Paula Rio

    CIEMAT/CIBERER/IIS-FJD, Universidad Autónoma de Madrid

    Paula is the Head of the Bone Marrow Failure Unit at CIEMAT/CIBERER/IIS-FJD at the Universidad Autónoma in Madrid.

    Google Scholar ORCIID LinkedIn Unit Webpage

  • Pia Johansson

    Pia Johansson

    Lund University, Sweden

    Pia is the Scientific Coordinator of the Cell and Gene Therapy Core at Lund University.

    Google Scholar ORCIID LinkedIn Lab Webpage

  • Rasmus O. Bak

    Rasmus O. Bak

    Aarhus University, Denmark

    Rasmus is a tenured Associate Professor at the Department of Biomedicine at Aarhus University. He is also the co-founder of UNIKUM Therapeutics.

    Google Scholar ORCIID LinkedIn Lab Webpage

  • Roberto Nitsch

    Roberto Nitsch

    AstraZeneca

    Roberto is the Associate Director of Gene Therapy Safety Group at AstraZeneca.

    Google Scholar LinkedIn Company Webpage

  • Samanta Maragh

    Samanta Maragh

    National Institute of Standards & Technology, USA

    Samantha is the Leader of the Gene Editing Program at the National Institute of Standards & Technology, in the USA.

    LinkedIn Consortium Webpage

  • Seung Wook Yang

    Seung Wook Yang

    Amgen

    Seung is a Principal Scientist at Amgen.

    Google Scholar ORCIID LinkedIn Company Webpage

  • Simone Spuler

    Simone Spuler

    Charité Universistätsmedizin Berlin / Max Delbrück Center

    Simone is a Full Professor at Charité Universistätsmedizin Berlin and a Group Leader at Max Delbrück Center, in Germany.

    LinkedIn Google Scholar ORCIID Lab Webpage

  • Stefano Stella

    Stefano Stella

    Ensoma

    Stefano is the Vice-President of Gene Editing at Ensoma, and the Founder and Chief Technology Officer at Twelve Bio. He is also an Ass. Prof. at the Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Denmark.

    ORCIID LinkedIn Company Webpage

  • Toni Cathomen

    Toni Cathomen

    University of Freiburg, Germany

    Toni is the Director of the Institute for Transfusion Medicine and Gene Therapy in the University Medical Centre in Freiburg. He is also a Professor of Gene and Cell Therapy at the University of Freiburg.

    Google Scholar ORCIID LinkedIn Institute Webpage

  • Veronika Jekerle

    Veronika Jekerle

    European Medicines Agency (EMA)

    Veronika Jekerle is Head of Pharmaceutical Quality, Human Division, at the European Medicines Agency (EMA), Amsterdam, NL.

    Veronika will speak at the CRISPRMED24 Virtual Event 22nd April and be a panelist in the Panel Discussion: Standards and Regulations, 24th April.

  • Xavier Duportet

    Xavier Duportet

    Eligo Bioscience

    Xavier is the co-founder and CEO of Eligo Bioscience. He also co-founded Deeptech Founders and Hello Tomorrow, and is part of the Advisory Boards at Université Paris-Saclay and Universcience.

    Google Scholar LinkedIn Company Webpage

  • Yonglun Luo

    Yonglun Luo

    Aarhus University, Denmark

    Yonglun is a Professor in Gene and Stem Cell Technology at the Department of Biomedicine at Aarhus University. He is also an Affiliated Researcher at the Steno Diabetes Center in Aarhus, as well as the Executive Director at the Lars Bolund Institute of Regenerative Medicine.

    Google Scholar ORCIID LinkedIn Lab Webpage

  • Waseem Qasim

    Waseem Qasim

    UCL Great Ormond Street Institute of Child Health, UK

    Waseem is a Consultant in Paediatric Immunology and a Prof. of Cell & Gene Therapy at the Infection, Immunity & Inflammation Department at University College London (UCL) Great Ormond Street (GOS) Institute of Child Health

    Google Scholar ORCIID LinkedIn Lab Webpage

  • Zhenya Ivakine

    Zhenya Ivakine

    The Hospital for Sick Children

    Zhenya is a Group Leader at The Hospital for Sick Children in Toronto, Canada.

    LinkedIn Google Scholar ORCIID Lab Webpage

Sponsored talks by industry speakers

  • Ashley Jacobi

    Ashley Jacobi

    Integrated DNA Technologies

    Ashley is the Director of Applications & Market Development at Integrated DNA Technologies.

    LinkedIn ORCIID Company Webpage

  • Fan Zhou

    Fan Zhou

    GenScript Biotech

    Dr. Fan Zhou, PhD, is a senior scientist of molecular biology at GenScript Biotech.

  • Hao Wu

    Hao Wu

    Full Circles Therapeutics/Stellate DNA, USA

    Hao is the Co-Founder and CSO of Full Circles Therapeutics, as well as the Director of Stellate DNA.

    LinkedIn Company Webpage

  • Iván Hernández

    Iván Hernández

    Iván is the CSO of Countagen AB.

    LinkedIn Company Webpage

    Iván will speak at the CRISPRMED24 Virtual Event 22nd April.

  • Kevin Holden

    Kevin Holden

    Synthego

    Kevin is the Head of Science & Applied Research at Synthego. He is also a Scientific Advisor at Minus.

    ORCIID Linkedin Company Webpage

  • Paul Diehl

    Paul Diehl

    Cellecta

    Paul is the Chief Operating Officer and Director of Business Development at Cellecta.

    LinkedIn Company Webpage

  • Raoul Hennig

    Raoul Hennig

    BioSpring

    Raoul Hennig, Ph.D. is Head of Manufacturing Site II at BioSpring

    LinkedIn Company Webpage

  • Sidsel Alsing

    Sidsel Alsing

    Samplix

    Sidsel is a Field Application Scientist at Samplix

    LinkedIn Company Webpage

  • Simon Reed

    Simon Reed

    Broken String Biosciences

    Simon is the Co-Founder and CSO at Broken String Biosciences.

    LinkedIn Company Webpage

  • Vasileios Georgakakos

    Vasileios Georgakakos

    Clean Cells

    Vasileios is a Cytogenetics Manager at Clean Cells.

    LinkedIn Company Webpage